Posts in Peer Reviewed Articles
Daily solriamfetol improved difficulty with memory and thinking in people with obstructive sleep apnea and excessive daytime sleepiness experiencing such difficulty

Leary EB, Van Dongen HPA, Drake C, Bogan R, Jaeger J, Streicher C, Tabuteau H. Daily solriamfetol improved difficulty with memory and thinking in people with obstructive sleep apnea and excessive daytime sleepiness experiencing such difficulty: a plain language summary. Postgraduate Medical Journal – In Revision.

Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP)

Leary EB*, Van Dongen HPA*, Drake C, Bogan R, Jaeger J, Rosenberg R, Streicher C, Tabuteau H. Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP): A Randomized Placebo-Controlled Double-Blind Repeated-Measures Crossover Phase IV Clinical Trial of the Effect of the Wake-Promoting Agent Solriamfetol on Cognitive Function in OSA With Excessive Daytime Sleepiness and Cognitive Impairment. Chest. 2024 Nov 9: S0012-3692(24)05470-9. DOI: 10.1016/j.chest.2024.10.050. Epub ahead of print. PMID: 39528111. (* equal contribution)

Fatigued but not sleepy? An empirical investigation of the differentiation between fatigue and sleepiness in sleep disorder patients in a cross-sectional study

Suh S, Lok R, Weed L, Cho A, Mignot E, Leary EB; STAGES cohort investigator group; Zeitzer JM. Fatigued but not sleepy? An empirical investigation of the differentiation between fatigue and sleepiness in sleep disorder patients in a cross-sectional study. J Psychosom Res. 2024 Feb 9;178:111606. DOI: 10.1016/j.jpsychores.2024.111606. PMID: 38359639.

Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study

Husain AM, Zee PC, Leary EB, Fuller DS, Macfadden W, Candler S, Whalen M, Bae CJ. Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study. Sleep Med. 2024 Jan;113:328-337. DOI: 10.1016/j.sleep.2023.11.022. Epub 2023 Nov 25. PMID: 38103464.

Proteomic insights into the pathophysiology of periodic limb movements and restless legs syndrome

Cederberg KLJ, Peris Sempere V, Lin L, Zhang J, Leary EB, Moore H, Morse AM, Blackman A, Schweitzer PK, Kotagal S, Bogan R, Kushida CA, STAGES Cohort Investigator Group, Mignot E. Proteomic insights into the pathophysiology of periodic limb movements and restless legs syndrome. Sleep Health. 2023 Aug 8:S2352-7218(23)00130-4. DOI: 10.1016/j.sleh.2023.06.008. PMID: 37563071.

Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study

Bae CJ, Zee PC, Leary EB, Fuller DS, Macfadden W, Candler S, Steininger TL, Husain AM. Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study. Sleep Med. 2023 Sep;109:65-74. DOI: 10.1016/j.sleep.2023.05.023. Epub 2023 Jun 19. PMID: 37421868.

Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Pathophysiology of Presence, Severity, and Treatment Response

Cederberg KLJ, Hanif U, Peris Sempere V, Hédou J, Leary EB, Schneider LD, Lin L, Zhang J, Morse AM, Blackman A, Schweitzer PK, Kotagal S, Bogan R, Kushida CA, Ju YS, Petousi N, Turnbull CD, Mignot E, The Stages Cohort Investigator Group. Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Pathophysiology of Presence, Severity, and Treatment Response. Int J Mol Sci. 2022 Jul 20;23(14):7983. DOI: 10.3390/ijms23147983. PMID: 35887329; PMCID: PMC9317550.